Acute blockade of CB1 receptor leads to reinstatement of MDMA-induced conditioned place preference

Pharmacology Biochemistry and Behavior

Volumn 100, Issue 1, 2011, Pages 33-39

  Daza Losada, M ^a   Minarro J ^a   Aguilar, M A ^a   Valverde, O ^b   Rodriguez Arias M ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Cannabinoids; Ecstasy; Place preference; Polyabuse; Reinstatement

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; RIMONABANT; UNCLASSIFIED DRUG; WIN 55 212 2;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; DRUG SEEKING BEHAVIOR; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RECEPTOR BLOCKING; REWARD; TREATMENT OUTCOME;

ANIMALS; BENZOXAZINES; CANNABINOIDS; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-SEEKING BEHAVIOR; MALE; MICE; MORPHOLINES; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NAPHTHALENES; RECEPTOR, CANNABINOID, CB1;

CANNABIS; MUS;

EID: 80051582610     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.07.011     Document Type: Article

References (87)

1. M.M. Ahmed, S. Rajpal, C. Sweeney, T.A. Gerovac, B. Allcock, and S. McChesney Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain Spine 10 2010 1049 1054
2. E. Alves, T. Summavielle, C.J. Alves, J.B. Custódio, E. Fernandes, and M. de Lourdes Bastos Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A Addict Biol 14 2009 185 193
3. K. Anggadiredja, M. Nakamichi, T. Hiranita, H. Tanaka, Y. Shoyama, and S. Watanabe Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade Neuropsychopharmacology 29 2004 1470 1478 (Pubitemid 38982239)
4. L. Bellocchio, P. Lafenêtre, A. Cannich, D. Cota, N. Puente, and P. Grandes Bimodal control of stimulated food intake by the endocannabinoid system Nat Neurosci 13 3 2010 281 283
5. A.L. Bodor, I. Katona, G. Nyiri, K. Mackie, C. Ledent, and N. Hajos Endocannabinoid signaling in rat somatosensory cortex:Laminar differences and involvement of specific interneuron types J Neurosci 25 2005 6845 6856 (Pubitemid 41023152)
6. M. Bortolato, P. Campolongo, R.A. Mangieri, M.L. Scattoni, R. Frau, and V. Trezza Anxiolytic-like properties of the anandamide transport inhibitor AM404 Neuropsychopharmacology 31 2006 2652 2659 (Pubitemid 44764162)
7. D. Braida, and M. Sala Role of the endocannabinoid system in MDMA intracerebral self-administration in rats Br J Pharmacol 136 2002 1089 1092 (Pubitemid 34970059)
8. D. Braida, S. Iosuè, S. Pegorini, and M. Sala 3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system Pharmacol Res 51 2005 177 182 (Pubitemid 40040550)
9. R.A. Chambers, J.R. Taylor, and M.N. Potenza Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability Am J Psychiatry 160 2003 1041 1052 (Pubitemid 41070962)
10. A. Cippitelli, A. Bilbao, A.C. Hansson, I. del Arco, W. Sommer, and M. Heilig Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats Eur J Neurosci 21 2005 2243 2251 (Pubitemid 40695249)
11. G. Colombo, S. Serra, G. Brunetti, R. Gomez, S. Melis, and G. Vacca Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats Psychopharmacology 159 2002 181 187 (Pubitemid 34146562)
12. M. Daza-Losada, B. Ribeiro Do Couto, C. Manzanedo, M.A. Aguilar, M. Rodríguez-Arias, and J. Miñarro Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice Neuropsychopharmacology 32 2007 1750 1759 (Pubitemid 47076389)
13. T.J. De Vries, Y. Shaham, J.R. Homberg, H. Crombag, K. Schuurman, and J. Dieben Cannabinoid mechanism in relapse to cocaine seeking Nat Med 7 2001 1151 1154 (Pubitemid 33010025)
14. T.J. De Vries, J.R. Homberg, R. Binnekade, H. Raasø, and A.N. Schoffelmeer Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats Psychopharmacology 168 2003 164 169 (Pubitemid 36851175)
15. T.J. De Vries, W. de Vries, M.C. Janssen, and A.N. Schoffelmeer Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A Behav Brain Res 161 2005 164 168 (Pubitemid 40719783)
16. W.A. Devane, F.A. Dysarz, M.R. Johnson, L.S. Melvin, and A.C. Howlett Determination and characterization of a cannabinoid receptor in rat brain Mol Pharmacol 34 1988 605 613 (Pubitemid 19007296)
17. D. Economidou, L. Mattioli, C. Cifani, M. Perfumi, M. Massi, and V. Cuomo Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats Psychopharmacology 183 2006 394 403 (Pubitemid 41721140)
18. L. Fattore, M.C. Martellotta, G. Cossu, M.S. Mascia, and W. Fratta CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats Behav Brain Res 104 1999 141 146 (Pubitemid 29421642)
19. L. Fattore, M.S. Spano, G. Cossu, S. Deiana, and W. Fratta Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats Eur J Neurosci 17 2003 1723 1726 (Pubitemid 36628140)
20. L. Fattore, S. Spano, G. Cossu, S. Deiana, P. Fadda, and W. Fratta Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats Neuropharmacology 48 2005 1097 1104 (Pubitemid 40725982)
21. L. Fattore, P. Fadda, and W. Fratta Endocannabinoid regulation of relapse mechanisms Pharmacol Res 56 2007 418 427 (Pubitemid 350026394)
22. L. Fattore, M.S. Spano, S. Deiana, V. Melis, G. Cossu, and P. Fadda An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives Brain Res Rev 53 2007 1 16 (Pubitemid 44854208)
23. L. Fattore, P. Fadda, M.S. Spano, M. Pistis, and W. Fratta Neurobiological mechanisms of cannabinoid addiction Mol Cell Endocrinol 286 2008 S97 S107
24. B. Ferrer, M.A. Gorriti, A. Palomino, I. Gornemann, Y. de Diego, and F.J. Bermudez-Silva Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies Eur J Pharmacol 559 2007 180 183 (Pubitemid 46295416)
25. J.E. Gallate, T. Saharov, P.E. Mallet, and I.S. McGregor Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist Eur J Pharmacol 370 1999 233 240 (Pubitemid 29192867)
26. M.S. García-Gutiérrez, J.M. Pérez-Ortiz, A. Gutiérrez-Adán, and J. Manzanares Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors Br J Pharmacol 160 2010 1773 1784
27. E.L. Gardner Endocannabinoid signaling system and brain reward: emphasis on dopamine Pharmacol Biochem Behav 81 2005 263 284 (Pubitemid 40807127)
28. E.L. Gardner, and S.R. Vorel Cannabinoid transmission and reward-related events Neurobiol Dis 5 1998 502 533 (Pubitemid 29075848)
29. G.L. Gessa, M. Melis, A.L. Muntoni, and M. Diana Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors Eur J Pharmacol 341 1998 39 44 (Pubitemid 28041196)
30. A. Giuffrida, L.H. Parsons, T.M. Kerr, F. Rodríguez de Fonseca, M. Navarro, and D. Piomelli Dopamine activation of endogenous cannabinoid signaling in dorsal striatum Nat Neurosci 2 1999 358 363 (Pubitemid 30491279)
31. L. Heng, J.A. Beverley, H. Steiner, and K.Y. Tseng Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic/associative and sensorimotor cortical areas Synapse 65 2011 278 286
32. H. Hermann, G. Marsicano, and B. Lutz Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain Neuroscience 109 2002 451 460 (Pubitemid 34121997)
33. P.W. Kalivas, and C. O'Brien Drug addiction as a pathology of staged neuroplasticity Neuropsychopharmacology 33 2008 166 180 (Pubitemid 350191316)
34. R.S. Landsman, T.H. Burkey, P. Consroe, W.R. Roeske, and H.I. Yamamura SR141716A is an inverse agonist at the human cannabinoid CB1 receptor Eur J Pharmacol 334 1 1997 R1 R2
35. J. Laszlo, V.S. Lucas Jr., D.C. Hanson, C.M. Cronin, and S.E. Sallan Levonantradol for chemotherapy-induced emesis: phase I-II oral administration J Clin Pharmacol 21 1981 51S 56S
36. B. Le Foll, and S.R. Goldberg Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence J Pharmacol Exp Ther 312 2005 875 883 (Pubitemid 40293744)
37. C. Ledent, O. Valverde, G. Cossu, F. Petitet, J.F. Aubert, and F. Beslot Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice Science 283 1999 401 404
38. C.R. Lupica, A.C. Riegel, and A.F. Hoffman Marijuana and cannabinoid regulation of brain reward circuits Br J Pharmacol 143 2004 227 234 (Pubitemid 39315142)
39. R. Maldonado, O. Valverde, and F. Berrendero Involvement of the endocannabinoid system in drug addiction Trends Neurosci 29 2006 225 232
40. C. Manzanedo, M.A. Aguilar, M. Rodríguez-Arias, M. Navarro, and J. Miñarro Cannabinoid agonist-induced sensitisation to morphine place preference in mice Neuroreport 15 8 2004 1373 1377 7 (Pubitemid 38757284)
41. C. Manzanedo, M. Rodríguez-Arias, M. Daza-Losada, C. Maldonado, M.A. Aguilar, and J. Miñarro Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice Behav Brain Funct 6 2010 19
42. A.B. Martín, E. Fernandez-Espejo, B. Ferrer, M.A. Gorriti, A. Bilbao, and M. Navarro Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors Neuropsychopharmacology 33 2008 1667 1679 (Pubitemid 351684717)
43. S. Mato, A. Pazos, and E.M. Valdizan Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain Eur J Pharmacol 443 2002 43 46 (Pubitemid 34603596)
44. I.S. McGregor, K.D. Dam, P.E. Mallet, and J.E. Gallate Delta9-THC reinstates beer- and sucrose-seeking behaviour in abstinent rats: comparison with midazolam, food deprivation and predator odour Alcohol Alcohol 40 2005 35 45
45. V. Mendizábal, A. Zimmer, and R. Maldonado Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice Neuropsychopharmacology 31 2006 1957 1966
46. T.H. Moore, S. Zammit, A. Lingford-Hughes, T.R. Barnes, P.B. Jones, and M. Burke Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review Lancet 370 2007 319 328 (Pubitemid 47094993)
47. J. Mørland Toxicity of drug abuse-amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use Toxicol Lett 112-113 2000 147 152 (Pubitemid 30138116)
48. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65 (Pubitemid 23305569)
49. J.E. Murray, and R.A. Bevins Cannabinoid conditioned reward and aversion: behavioral and neural processes ACS Chem Neurosci 1 2010 265 278
50. M. Nakazi, U. Bauer, T. Nickel, M. Kathmann, and E. Schlicker Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors Naunyn Schmiedebergs Arch Pharmacol 361 2000 19 24 (Pubitemid 30064649)
51. M. Navarro, E. Hernández, R.M. Muñoz, I. del Arco, M.A. Villanúa, and M.R. Carrera Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat Neuroreport 8 1997 491 496 (Pubitemid 27180108)
52. R. Noyes Jr., S.F. Brunk, D.A. Baram, and A. Canter Analgesic effect of delta-9-tetrahydrocannabinol J Clin Pharmacol 15 1975 139 143
53. E.S. Onaivi, A. Chakrabarti, E.T. Gwebu, and G. Chaudhuri Neurobehavioral effects of delta 9-THC and cannabinoid (CB1) receptor gene expression in mice Behav Brain Res 72 1995 115 125
54. L. Orio, S. Edwards, O. George, L.H. Parsons, and G.F. Koob A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions J Neurosci 29 2009 4846 4857
55. D. Parolaro, and T. Rubino The role of the endogenous cannabinoid system in drug addiction Drug News Perspect 21 2008 149 157 (Pubitemid 351809138)
56. D. Piomelli The endocannabinoid system: a drug discovery perspective Curr Opin Investig Drugs 6 2005 672 679 (Pubitemid 40904037)
57. D. Raft, J. Gregg, J. Ghia, and L. Harris Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response Clin Pharmacol Ther 21 1977 26 33 (Pubitemid 8024156)
58. S. Ramiro-Fuentes, O. Ortiz, R. Moratalla, and E. Fernandez-Espejo Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors Neuroscience 167 2010 205 215
59. B. Ribeiro Do Couto, M.A. Aguilar, C. Manzanedo, M. Rodríguez- Arias, A. Armario, and J. Miñarro Social stress is as effective as physical stress in reinstating morphine-induced place preference in mice Psychopharmacology 185 2006 459 470
60. P. Robledo, J.M. Trigo, F. Panayi, R. de la Torre, and R. Maldonado Behavioural and neurochemical effects of combined MDMA and THC administration in mice Psychopharmacology 195 2007 255 264 (Pubitemid 350045837)
61. F. Rodríguez de Fonseca, J.L. Martín Calderón, R. Mechoulam, and M. Navarro Repeated stimulation of D1 dopamine receptors enhances (-)-11-hydroxy-delta 8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats Neuroreport 5 1994 761 765
62. F. Rodríguez de Fonseca, M.R. Carrera, M. Navarro, G.F. Koob, and F. Weiss Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal Science 276 1997 2050 2054 (Pubitemid 27443612)
63. F. Rodríguez de Fonseca, I. Del Arco, J.L. Martín- Calderón, M.A. Gorriti, and M. Navarro Role of the endogenous cannabinoid system in the regulation of motor activity Neurobiol Dis 5 1998 483 501 (Pubitemid 29075847)
64. M. Rodríguez-Arias, C. Manzanedo, C. Roger-Sánchez, B.R. Do Couto, M.A. Aguilar, and J. Miñarro Effect of adolescent exposure to WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference Prog Neuropsychopharmacol Biol Psychiatry 34 2010 166 171
65. M.C. Sañudo-Peña, K. Tsou, E.R. Delay, A.G. Hohman, M. Force, and J.M. Walker Endogenous cannabinoids as an aversive or counter-rewarding system in the rat Neurosci Lett 223 1997 125 128 (Pubitemid 27112792)
66. M.C. Sañudo-Peña, M. Force, K. Tsou, A.S. Miller, and J.M. Walker Effects of intrastriatal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system Synapse 30 1998 221 226 (Pubitemid 28376381)
67. S. Schenk, D. Gittings, and J. Colussi-Mas Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats Br J Pharmacol 162 2011 1770 1780
68. E. Schlicker, and M. Kathmann Modulation of transmitter release via presynaptic cannabinoid receptors Trends Pharmacol Sci 22 2001 565 572 (Pubitemid 33042646)
69. M. Schneider Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure Addict Biol 13 2008 253 263 (Pubitemid 351692985)
70. Y. Shaham, U. Shalev, L. Lu, H. de Wit, and J. Stewart The reinstatement model of drug relapse: history, methodology and major findings Psychopharmacology 168 2003 3 20 (Pubitemid 36851158)
71. U. Shalev, J.W. Grimm, and Y. Shaham Neurobiology of relapse to heroin and cocaine seeking: a review Pharmacol Rev 54 2002 1 42 (Pubitemid 34208828)
72. M. Shoaib The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats Neuropharmacology 54 2008 438 444
73. M. Solinas, L.V. Panlilio, G. Tanda, A. Makriyannis, S.A. Matthews, and S.R. Goldberg Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats Neuropsychopharmacology 30 2005 2046 2057 (Pubitemid 43093504)
74. M. Solinas, S.R. Goldberg, and D. Piomelli The endocannabinoid system in brain reward processes Br J Pharmacol 154 2008 369 383 (Pubitemid 351670594)
75. M.S. Spano, L. Fattore, G. Cossu, S. Deiana, P. Fadda, and W. Fratta CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat Br J Pharmacol 143 2004 343 350 (Pubitemid 39424822)
76. L.P. Spear The adolescent brain and age-related behavioral manifestations Neurosci Biobehav Rev 24 2000 417 463 (Pubitemid 30243061)
77. G. Tanda, F.E. Pontieri, and G. Di Chiara Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism Science 276 1997 2048 2050 (Pubitemid 27443611)
78. C. Touriño, R. Maldonado, and O. Valverde MDMA attenuates THC withdrawal syndrome in mice Psychopharmacology 193 2007 75 84 (Pubitemid 46906631)
79. C. Touriño, C. Ledent, R. Maldonado, and O. Valverde CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement Biol Psychiatry 63 2008 1030 1038 (Pubitemid 351636293)
80. United Nations Office on Drugs and Crime (UNODC) World Drug Report 2010 United Nations Publication Sales No. E.10.XI.13
81. E. Valjent, and R. Maldonado A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice Psychopharmacology 147 2000 436 438 (Pubitemid 30048492)
82. E. Valjent, J.M. Mitchell, M.J. Besson, J. Caboche, and R. Maldonado Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine Br J Pharmacol 135 2002 564 578 (Pubitemid 34151189)
83. S. Vlachou, G.G. Nomikos, and G. Panagis WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation Behav Brain Res 141 2003 215 222 (Pubitemid 36542969)
84. S. Vlachou, F. Stamatopoulou, G.G. Nomikos, and G. Panagis Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine Int J Neuropsychopharmacol 11 2008 905 923
85. F. Weiss Neurobiology of craving, conditioned reward and relapse Current Opinion Pharmacol 5 2005 9 19 (Pubitemid 40124529)
86. R.I. Wilson, and R.A. Nicoll Endocannabinoid signaling in the brain Science 296 2002 678 682
87. M.R. Zarrindast, M. Nouri, and S. Ahmadi Cannabinoid CB1 receptors of the dorsal hippocampus are important for induction of conditioned place preference (CPP) but do not change morphine CPP Brain Res 1163 2007 130 137 (Pubitemid 47125867)